Leukocytoclastic vasculitis;Leukozytoklastishe vaskulitis

Hautarzt

Volumn 55, Issue 8, 2004, Pages 759-785

  Sunderkotter C ^a   Roth, J ^b   Bonsmann, G ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

ANCA; Henoch Sch nlein purpura; Hypersensitivity vasculitis; Immune complex; Leukocytoclastic vasculitis, purpura

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; C REACTIVE PROTEIN; CEFACLOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DNA ANTIBODY; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RHEUMATOID FACTOR; SULFONAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ALLERGIC VASCULITIS; ANAPHYLACTOID PURPURA; ANTIBODY DETECTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG USE; FULMINATING PURPURA; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LABORATORY TEST; LEUKOCYTOCLASTIC VASCULITIS; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SEPSIS; SKIN BIOPSY; SYMPTOMATOLOGY; VASCULITIS; ADOLESCENT; ADULT; ARTICLE; BLOOD; CAPILLARY; CHILD; CHRONIC DISEASE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE MICROSCOPY; IMMUNE COMPLEX DISEASE; PATHOLOGY; RECURRENT DISEASE; SKIN; VASCULARIZATION;

ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CAPILLARIES; CHILD; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNE COMPLEX DISEASES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSCOPY, FLUORESCENCE; PURPURA, SCHOENLEIN-HENOCH; RECURRENCE; SKIN; VASCULITIS, ALLERGIC CUTANEOUS; VASCULITIS, HYPERSENSITIVITY;

EID: 4344601502     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0760-1     Document Type: Review

References (53)

1. Baumgartel MW, Sunderkötter C, Glockner WM, Kolde G (1994) Essential cryofibrinogenemia with generalized livedo racemosa. Hautarzt 45:243-248
2. Belmont HM, Abramson SB, Lie JT (1996) Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 39:9-22
3. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M (1998) Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore) 77:403-418
4. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, et al. (1997) Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859-864
5. Braverman IM, Yen A (1975) Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis. J Invest Dermatol 64:105-112
6. Calabrese LH, Duna GF (1996) Drug-induced vasculitis. Curr Opin Rheumatol 8:34-40
7. Calabrese LH, Michel BA, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108-1113
8. Cassidy JT, Petty RE (1995) Textbook of pediatric rheumatology, 3rd edn. WB Saunders Co.
9. Cioc AM, Sedmak DD, Nuovo GJ et al. (2002) Parvovirus B19 associated adult Henoch Schonlein purpura. J Cutan Pathol 29:602-607
10. Clauss M, Sunderkötter C, Sveinbjornsson B et al. (2001) A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. Blood 97:1321-1329
11. Colakovski H, Lorber DL (2001) Propylthiouracil-induced perinuclear-staining antineutrophil cytoplasmic autoantibody-positive vasculitis in conjunction with pericarditis. Endocr Pract 7:37-39
12. Costner MI, Sontheimer RD, Provost T (2004) Lupus erythematosus. In: Sontheimer RG, Provost T (eds) Cutaneous manifestations of rheumatic diseases, 2nd edn. Williams & Wilkins Co., Philadelphia, pp 15-64
13. Daoud MS, Gibson LE, DeRemee RA et al. (1994) Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 31:60S-612
14. Davis MD, Daoud MS, Kirby B et al. (1998) Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol 38:899-905
15. Fiorentino DF (2003) Cutaneous vasculitis. J Am Acad Dermatol 48:311-340
16. Garcia-Porrua C, Calvino MC, Llorca J et al. (2002) Henoch-Schonlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32:149-156
17. Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schonlein nephritis. Lancet 339:280-282
18. Goraya JS, Kaur S (2002) Acute infantile hemorrhagic edema and Henoch-Schonlein purpura: is IgA the missing link? J Am Acad Dermatol 47:801; author reply 801-802
19. Groger M, Sarmay G, Fiebiger E et al. (1996) Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. J Immunol 156:1549-1556
20. Hene RJ, Velthuis P, van de Wiel A et al. (1986) The relevance of IgA deposits in vessel walls of clinically normal skin. A prospective study. Arch Intern Med 146:745-749
21. Hunder GG, Arend WP, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33:1065-1067
22. Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
23. Jessop SJ (1995) Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol 34:942-945
24. Julian BA, Waldo FB, Rifai A, Mestecky J (1988) IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 84:129-132
25. Lentsch AB, Ward PA (2000) Regulation of inflammatory vascular damage. J Pathol 190:343-348
26. Levy M, Broyer M, Arsan A et al. (1976) Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp 6:183-228
27. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL (1998) Cutaneous small-vessel vasculitis. J Am Acad Dermatol 39:667-687; quiz 688-690
28. Mannik M (1989) Development of immune complexes in the skin. J Invest Dermatol 93:73S-77S
29. Mehregan DR, Hall MJ, Gibson LE (1992) Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 26:441-448
30. Michel BA, Hunder GG, Bloch DA, Calabrese EH (1992) Hypersensitivity vasculitis and Henoch-Schonlein purpura: a comparison between the 2 disorders. J Rheumatol 19:721-728
31. Mills JA, Michel BA, Bloch DA et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schonlein purpura. Arthritis Rheum 33:1114-1121
32. Nashan D, Sunderkötter C, Bonsmann G et al. (1995) Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome? Br J Dermatol 133:132-134
33. Piette W (2004) Primary systemic vasculitis. In: Sonthelmer RD, Provost T (eds) Cutaneous manifestations of rheumatic diseases, 2nd edn. Williams & Wilkins Co., Philadelphia, pp 159-196
34. Piette WW (1997) What is Schonlein-Henoch purpura, and why should we care? Arch Dermatol 133:515-518
35. Pillebout E, Thervet E, Hill G et al. (2002) Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271-1278
36. Pozzi C, Bolasco PG, Fogazzi GB et al. (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353:883-887
37. Sais G, Vida Iler A, Jucgla A et al. (1995) Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol 131:1399-1402
38. Sais G, Vidaller A, Jucgla A et al. (1998) Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol 134:309-315
39. Saulsbury FT (1999) Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 78:395-409
40. Schifferli JA (1996) Complement and immune complexes. Res Immunol 147:109-110
41. Schifferli JA, Ng YC, Peters DK (1986) The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 31S:488-495
42. Somer T, Finegold SM (1995) Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 20:1010-1036
43. Sunderkötter C, Kolde G (in press) Cutaneous vasculitis. In: Bos J (ed) Skin Immune System (SIS). Cutaneous immunology and clinical immunodermatology, 3rd edn. CRC Press, Boca Raton New York
44. Sunderkötter C, Bonsmann G, Roth J (in press) Vaskulitiden, Vaskulopathien, Pannikulitiden und Differential-diagnose. In: Traupe H, Hamm H (eds) Pädiatrische Dermatologie, 2nd edn. Springer, Berlin Heidelberg New York Tokyo
45. Sunderkötter C, Seeliger S, Schonlau F et al. (2001) Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol 10:391-404
46. Swerlick RA, Lawley TJ (1989) Cutaneous vasculitis: its relationship to systemic disease. Med Clin North Am 73:1221-1235
47. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD et al. (1997) Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases. Arch Dermatol 133:438-442
48. ten Holder S M, Joy MS, Falk RJ (2002) Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 36:130-147
49. Trejo O, Ramos-Casals M, Garcia-Carrasco M et al. (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80:252-262
50. Van Hale HM, Gibson LE, Schroeter AL (1986) Henoch-Schonlein vasculitis: direct immunofluorescence study of uninvolved skin. J Am Acad Dermatol 1S:66S-670
51. Wilkinson SM, English IS, Smith NP et al. (1992) Erythema elevatum diutinum: a clinicopathological study. Clin Exp Dermatol 17:87-93
52. Wisnieski JJ (2000) Urticarial vasculitis. Curr Opin Rheumatol 12:24-31
53. Zaja F, De Vita S, Mazzaro C et al. (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827-3834